Kang Fang Biotech announced that on October 14, 2026, the Company entered into a placement agreement with the placement agent. The Company has agreed to place a total of 20 million shares to no less than six undertakers through the placement agent at a price of HK$97.76 per share. The placement price of HK$97.76 per share is approximately 6.90% off of the closing price of HK$105.00 per share reported on the Stock Exchange on October 13, 2026. The placed shares will account for approximately 2.13% of the company's expanded issued share capital. Assuming that all 20 million shares of the placed shares are fully subscribed, the total proceeds will be approximately HK$1,955 million after the placement is completed, and the net proceeds from the placement are estimated to be approximately HK$1,941 million.

Kang Fang Biotech announced that on October 14, 2026, the Company entered into a placement agreement with the placement agent. The Company has agreed to place a total of 20 million shares to no less than six undertakers through the placement agent at a price of HK$97.76 per share. The placement price of HK$97.76 per share is approximately 6.90% off of the closing price of HK$105.00 per share reported on the Stock Exchange on October 13, 2026. The placed shares will account for approximately 2.13% of the company's expanded issued share capital. Assuming that all 20 million shares of the placed shares are fully subscribed, the total proceeds will be approximately HK$1,955 million after the placement is completed, and the net proceeds from the placement are estimated to be approximately HK$1,941 million.